文献速递心脑血管急症

使用第5代心肌肌钙蛋白T检测超快速排除急性心肌梗死:REACTION-US研究结果

Ultrarapid Rule-out for Acute Myocardial Infarction Using the Generation 5 Cardiac Troponin T Assay: Results From the REACTION-US Study.
PubMed 文献 · Ann Emerg Med · 2018-08-14
一句话结论在单中心美国急诊科,基线第5代cTnT低于6 ng/L或基线低于8 ng/L且30分钟Δ低于3 ng/L可排除急性心肌梗死,分别适用于28.8%和41.0%的患者。

该研究在单中心美国急诊科纳入569例疑似急性冠脉综合征患者,基线及30分钟血样第5代cTnT由独立核心实验室批检测,急性心肌梗死由心内科和急诊科医师裁定。44例(7.7%)诊断为急性心肌梗死。基线cTnT低于6 ng/L者164例(28.8%),无急性心肌梗死,阴性预测值100%(95%CI 97.8%–100.0%),灵敏度100%(95%CI 92.0%–100.0%)。基线低于8 ng/L且30分钟Δ低于3 ng/L者221例(41.0%),无急性心肌梗死,阴性预测值100%(95%CI 98.3%–100.0%),灵敏度100%(95%CI 92.0%–100.0%)。作者认为需多中心美国研究进一步评估这些超快速排除策略,尤其需缩窄置信区间。

要点

  • 基线第5代cTnT低于6 ng/L者164例(28.8%),无急性心肌梗死,阴性预测值100%(95%CI 97.8%–100.0%),灵敏度100%(95%CI 92.0%–100.0%)。
  • 基线第5代cTnT低于8 ng/L且30分钟Δ低于3 ng/L者221例(41.0%),无急性心肌梗死,阴性预测值100%(95%CI 98.3%–100.0%),灵敏度100%(95%CI 92.0%–100.0%)。
  • 569例疑似急性冠脉综合征患者中44例(7.7%)诊断为急性心肌梗死。
  • 作者认为需多中心美国研究评估这些超快速排除策略,尤其需缩窄置信区间。

适用人群与场景

  • 美国单中心急诊科中因任何疑似急性冠脉综合征症状就诊的患者。

诊断标准与关键阈值

  • 基线第5代cTnT低于6 ng/L可排除急性心肌梗死。
  • 基线第5代cTnT低于8 ng/L且30分钟Δ低于3 ng/L可排除急性心肌梗死。

研究设计与关键结果

  • 研究类型为在单中心美国急诊科开展的前瞻性队列研究,纳入569例疑似急性冠脉综合征患者,44例(7.7%)诊断为急性心肌梗死。
  • 基线及30分钟血样第5代cTnT由独立核心实验室批检测,急性心肌梗死由心内科和急诊科医师裁定。
  • 基线cTnT低于6 ng/L者164例(28.8%),无急性心肌梗死,阴性预测值100%(95%CI 97.8%–100.0%),灵敏度100%(95%CI 92.0%–100.0%)。
  • 基线cTnT低于8 ng/L且30分钟Δ低于3 ng/L者221例(41.0%),无急性心肌梗死,阴性预测值100%(95%CI 98.3%–100.0%),灵敏度100%(95%CI 92.0%–100.0%)。

证据类型、等级与局限

  • 证据类型:单中心前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在单中心美国急诊科疑似急性冠脉综合征患者中,基线第5代cTnT低于6 ng/L或基线低于8 ng/L且30分钟Δ低于3 ng/L可排除急性心肌梗死,分别适用于28.8%和41.0%的患者。
  • 作者认为需多中心美国研究评估这些超快速急性心肌梗死排除策略,尤其需缩窄置信区间。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: We determine how well a new Food and Drug Administration-approved single cardiac troponin T (cTnT) Generation 5 baseline measurement below the level of quantification (6 ng/L) and a novel study-derived baseline and 30-minute cTnT Generation 5 algorithm might adequately exclude acute myocardial infarction in patients with suspected acute coronary syndrome in a US emergency department (ED).

METHODS: Patients presenting with any symptoms suspicious for acute coronary syndrome were enrolled at a single US ED. Baseline and 30-minute blood samples were obtained and cTnT Generation 5 levels were later batch analyzed in an independent core laboratory. Acute myocardial infarction diagnosis was adjudicated by a cardiologist and an emergency physician.

RESULTS: Of the 569 study patients, 44 (7.7%) had an acute myocardial infarction diagnosis. One hundred sixty-four patients (28.8%) had a presentation cTnT Generation 5 level less than 6 ng/L, and none of these individuals had an acute myocardial infarction (negative predictive value of 100% [95% confidence interval 97.8% to 100.0%] and sensitivity of 100% [95% confidence interval 92.0% to 100.0%]). A baseline cTnT Generation 5 value of less than 8 ng/L and a 30-minute Δ of less than 3 ng/L were present in 221 patients (41.0%), and none had acute myocardial infarction (negative predictive value of 100% [95% confidence interval 98.3% to 100.0%] and sensitivity of 100% [95% confidence interval 92.0% to 100.0%]).

CONCLUSION: In a single US ED, a single baseline cTnT Generation 5 measurement less than 6 mg/L and values at baseline less than 8 ng/L and a 30-minute Δ of less than 3 ng/L ruled out acute myocardial infarction in 28.8% and 41.0% of patients, respectively. Additional multicenter US studies evaluating these ultrarapid acute myocardial infarction rule-out guidelines are needed, especially to narrow the confidence intervals.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Nowak RM, Gandolfo CM, Jacobsen G, et al. Ultrarapid Rule-out for Acute Myocardial Infarction Using the Generation 5 Cardiac Troponin T Assay: Results From the REACTION-US Study. Ann Emerg Med. 2018. PMID: 30119942. doi:10.1016/j.annemergmed.2018.06.021

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。